Important note: Information in this article was accurate in 2006. The state of the art may have changed since the publication date. |
AIDS TREATMENT NEWS - June 29, 2006
India had the 2nd most abstracts accepted at the International AIDS Conference; Nigeria was 4th, Uganda 7th, and France 12th. We list the top 21 countries and number of accepted abstracts.:
The International AIDS Conference takes place every two years, and the 16th meeting will be in Toronto, Canada, August 13-18. A record 12,888 abstracts were submitted for blind peer review, and 9,826 are being published: 365 oral presentations, 200 poster-discussion presentations, 3,843 poster presentations, and 5,418 on the CD-ROM given to all participants. All will be published online.
Of the accepted abstracts, the top 21 countries with the number of abstracts accepted and scheduled to be presented were: United States 1819; India 723; Canada 606; Nigeria 594; South Africa 439; Brazil 405; Uganda 368; United Kingdom 316; Kenya 267; Thailand 259; China 218; France 171; Mexico 139; Zambia 136; Nepal 132; Cambodia 129; Tanzania 129; Russian Federation 112; Australia 105; Bangladesh 101; and Malawi 101. All abstract submission, even for "late breakers," is now closed.
Skills-building presentations were separately peer reviewed, and 86 were accepted of 766 submitted. A two million dollar scholarship program will allow 815 applicants to attend -- the great majority from resource-limited countries. Another program awarded 1,100 scholarships to Canadian residents.
For more information see http://www.aids2006.org/.
2006-06-29
ATN060607
Copyright © 2006 - by John S. James. See "Permission to Copy" at: http://www.aidsnews.org/canhelp. How to help AIDS Treatment News: http://www.aidsnews.org/canhelp.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, the National Library of Medicine, Roche and Trimeris, and donations from users like you.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV. Always watch for outdated information. This article first appeared in 2006. This material is designed to support, not replace, the relationship that exists between you and your doctor.
Copyright ©1980, 2006. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .